NUVASIVE (NUVA) Covered Calls

NUVASIVE covered calls NuVasive, Inc. is a medical device company focused on the design, development and marketing of products for the surgical treatment of spine disorders.

You can sell covered calls on NUVASIVE to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for NUVA (prices last updated Fri 4:16 PM ET):

NUVASIVE (NUVA) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
69.96 +1.31 49.00 70.05 674K 81 3.5B
Covered Calls For NUVASIVE (NUVA)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
Sep 21 70 2.15 67.90 3.1% 31.4%
Dec 21 70 4.80 65.25 7.3% 21.0%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

NuVasive, Inc. is a medical device company, which is focused on the design, development, and market of surgical products to treat the spine. Its products include a minimally disruptive surgical platform called Maximum Access Surgery, in addition to biologics, cervical and motion preservation products, and Intra-Operative Monitoring services. The surgical products for the spine include devices for the thoracolumbar spine, the cervical spine, and a set of motion. The product offerings that are still under development are primarily used to gain access to the spine to perform restorative and fusion procedures in a minimally disruptive fashion. Its biologic product line offerings include allograft, FormaGraft, a collagen synthetic product, Osteocel Plus, an allograft cellular matrix containing viable mesenchymal stem cells and AttraX, a synthetic bone graft material, all used to aid the spinal fusion process. The company was founded on July 21, 1997 and is headquartered in San Diego, CA.